📰 Edwarde Walsh News
Page 2 - Edwarde Walsh News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edwarde Walsh. Real-time updates on events, politics, business and more.
June 1, 2023
NEW YORK - Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved ABRYSVO , the companys bivalent RSV prefusion F vaccine, for the prevention of lower respiratory... | June 1, 2023
June 1, 2023
The FDA has approved Abrysvo for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
June 1, 2023
The approval for Abrysvo represents the second RSV vaccine approved for adults aged 60 years and older in the last month.
May 31, 2023
FDA’s decision is based on the data from the pivotal Phase 3 clinical trial in approximately 37,000 participants Each year in the U.S., it is estimated that between 60,000 and 160,000 older... | June 10, 2023
April 11, 2023
Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine.
October 21, 2022
WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.